Browsing Tag
COYA 302
3 posts
Can Coya Therapeutics de-risk IL-2 manufacturing ahead of trial results? Inside the $11.1m raise
Coya Therapeutics raises $11.1M in private placement led by Dr. Reddy’s to scale COYA 302 IL-2 manufacturing. Find out what it means for investors.
Coya Therapeutics gets FDA green light for Phase 2 ALS trial with COYA 302
Coya Therapeutics receives FDA clearance to initiate a Phase 2 trial of COYA 302 for ALS. Find out what this means for investors and the ALS drug pipeline.
Coya Therapeutics partners with Dr. Reddy’s for neurodegenerative disease therapy development
Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, has entered into a worldwide agreement with Dr. Reddy’s…